Literature DB >> 2454772

Expression of a C-reactive protein neoantigen (neo-CRP) in inflamed rabbit liver and muscle.

R F Rees1, H Gewurz, J N Siegel, J Coon, L A Potempa.   

Abstract

We have reported that human C-reactive protein (huCRP) can exist in two antigenically distinct forms which are observed as the native, pentameric, phosphorylcholine (PC)-binding CRP ("native-huCRP antigen"), and as a conformationally and physicochemically distinct free huCRP subunit ("neo-huCRP antigen"), respectively. We have demonstrated that forms of huCRP which preferentially express neo-huCRP antigenicity are naturally present on the surface of both normal human peripheral blood B lymphocytes and lymphocytes with natural killer cell activity. We have also reported that forms of huCRP expressing the neo-huCRP antigen have potent in vitro activities in platelet, polymorphonuclear leukocyte, and monocyte assays. In this study, we demonstrate a rabbit-CRP (raCRP) neoantigen can be expressed when isolated PC-binding raCRP is modified in analogy to huCRP. This "neo-raCRP" is cross-reactive with the neo-huCRP antigen and occurs naturally in acute phase but not normal rabbit liver and muscle. The relative distribution and localization of both antigens were comparable in tissue sections taken at 24 and 48 hr postinflammation elicited with typhoid vaccine. These data support the concept that CRP molecules expressing a structure and antigenicity which are distinct from native, pentagonal CRP do occur in vivo, and that such molecules accumulate at tissue sites of inflammation and necrosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2454772     DOI: 10.1016/0090-1229(88)90160-2

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  15 in total

1.  C-reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcgammaRIIB and SHIP-1.

Authors:  Keiji Tanigaki; Chieko Mineo; Ivan S Yuhanna; Ken L Chambliss; Michael J Quon; Ezio Bonvini; Philip W Shaul
Journal:  Circ Res       Date:  2009-05-07       Impact factor: 17.367

2.  Binding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: effects of phosphoethanolamine.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; David J Hammond; Antonio E Rusiñol; Lawrence A Potempa; Alok Agrawal
Journal:  Clin Chim Acta       Date:  2009-06-21       Impact factor: 3.786

3.  Carbohydrate ligands of human C-reactive protein: binding of neoglycoproteins containing galactose-6-phosphate and galactose-terminated disaccharide.

Authors:  Reiko T Lee; Yuan C Lee
Journal:  Glycoconj J       Date:  2006-07       Impact factor: 2.916

4.  Modified C-reactive protein might be a target autoantigen of TINU syndrome.

Authors:  Ying Tan; Feng Yu; Zhen Qu; Tao Su; Guang-Qun Xing; Li-Hua Wu; Feng-Mei Wang; Gang Liu; Liu Yang; Ming-Hui Zhao
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 8.237

5.  Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases.

Authors:  S A Bell; H Faust; A Schmid; M Meurer
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

Review 6.  Fcγ receptors and ligands and cardiovascular disease.

Authors:  Keiji Tanigaki; Nathan Sundgren; Amit Khera; Wanpen Vongpatanasin; Chieko Mineo; Philip W Shaul
Journal:  Circ Res       Date:  2015-01-16       Impact factor: 17.367

7.  C-reactive protein exists in an NaCl concentration-dependent pentamer-decamer equilibrium in physiological buffer.

Authors:  Azubuike I Okemefuna; Lasse Stach; Sudeep Rana; Akim J Ziai Buetas; Jayesh Gor; Stephen J Perkins
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

8.  Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein.

Authors:  Sanna Taskinen; Petri T Kovanen; Hanna Jarva; Seppo Meri; Markku O Pentikäinen
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

9.  Exercise-induced necrotic muscle damage and enzyme release in the four days following prolonged submaximal running in rats.

Authors:  J Komulainen; V Vihko
Journal:  Pflugers Arch       Date:  1994-10       Impact factor: 3.657

Review 10.  A hypothesis resolving the apparently disparate activities of native and altered forms of human C-reactive protein.

Authors:  M J Shields
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.